SCHEMBL28067912

SCHEMBL28067912

COc1cc(F)c([N+](=O)[O-])cc1NC(=O)OCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.53
NPC1 O15118 3/20 0.51
RAB9A P51151 3/20 0.51
LMNA P02545 2/20 0.47
MEN1 O00255 5/20 0.46
MAPT P10636 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
ALDH1A1 P00352 4/20 0.45
CTSV O60911 1/20 0.44
CTSL P07711 1/20 0.44
TP53 P04637 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
ACHE P22303 1/20 0.44
HTT P42858 2/20 0.44
PKM P14618 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
GAA P10253 1/20 0.43
CRHBP P24387 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7009210 0.88 NPC1 (0.50) KMT2ANPC1RAB9ALMNAMEN1
SCHEMBL28359300 0.82 NPC1 (0.47) KMT2ANPC1RAB9ALMNAMEN1
SCHEMBL28366989 0.81 KMT2A (0.49) KMT2ANPC1RAB9ALMNAMEN1
SCHEMBL9524084 0.81 LMNA (0.71) KMT2ALMNAMEN1MAPTALDH1A1
SCHEMBL5224480 0.81 ALDH1A1 (0.65) KMT2ALMNAMEN1MAPTL3MBTL1
SCHEMBL8346676 0.81 RAB9A (0.50) KMT2ANPC1RAB9ALMNAMEN1
SCHEMBL20680892 0.80 PKM (0.45) KMT2ANPC1RAB9ALMNAMEN1
SCHEMBL1895525 0.79 PDGFRA (0.53)
SCHEMBL29463677 0.78 LMNA (0.65) KMT2ANPC1RAB9ALMNAMEN1
SCHEMBL17653813 0.78 MGLL (0.54) KMT2ANPC1RAB9ALMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106883216-B Preparation method of oxitinib 张家港威胜生物医药有限公司 2020-03-13 CN disclosed
CN-105601620-A Method for preparing mereletinib mesylate BEIJING KANG LISHENG PHARMACEUTICAL TECH DEV CO LTD 2016-05-25 CN disclosed